C CARSGEN THERAPEUTICS
LIVE

Serial Number

79397815

Owner

CARSGEN THERAPEUTICS CO., LTD.

Attorney

Adam Bell

Filing Date

May 7, 2024

Add to watchlist:

No watchlists yet
View on USPTO

C CARSGEN THERAPEUTICS Trademark

Serial Number: 79397815 • Registration: 8163884

C CARSGEN THERAPEUTICS is a trademark filed by CARSGEN THERAPEUTICS CO., LTD. on May 7, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

CARSGEN THERAPEUTICS CO., LTD. (5 trademarks)

Building 12, No.388, Yindu Road,

Entity Type: 03

Trademark Details

Filing Date

May 7, 2024

Registration Date

March 10, 2026

Published for Opposition

January 20, 2026

Goods & Services

Diagnostic preparations for medical purposes; biological tissue cultures for medical purposes; stem cells for medical purposes; liquid medicines for the treatment of tumors, cancer, autoimmune diseases or disorders, inflammatory diseases, cardiovascular diseases, digestive system diseases, diabetes mellitus, endocrine and metabolic diseases, chronic respiratory diseases, nervous system diseases, bone and joint diseases, mental and psychological diseases, chronic kidney diseases, eye and ear diseases, congenital genetic cardiovascular and neurological diseases, infectious diseases, immune system related diseases and disorders, and blood diseases; injectable medicinal solutions in the nature of pharmaceutical preparations for the treatment of tumors, cancer, autoimmune diseases or disorders, inflammatory diseases, cardiovascular diseases, digestive system diseases, diabetes mellitus, endocrine and metabolic diseases, chronic respiratory diseases, nervous system diseases, bone and joint diseases, mental and psychological diseases, chronic kidney diseases, eye and ear diseases, congenital genetic cardiovascular and neurological diseases, infectious diseases, immune system related diseases and disorders, and blood diseases; pharmaceutical preparations for the treatment of tumors, cancer, autoimmune diseases or disorders, inflammatory diseases, cardiovascular diseases, digestive system diseases, diabetes mellitus, endocrine and metabolic diseases, chronic respiratory diseases, nervous system diseases, bone and joint diseases, mental and psychological diseases, chronic kidney diseases, eye and ear diseases, congenital genetic cardiovascular and neurological diseases, infectious diseases, immune system related diseases and disorders, and blood diseases; drugs for medical purposes in the nature of pharmaceutical preparations for the treatment of tumors, cancer, autoimmune diseases or disorders, inflammatory diseases, cardiovascular diseases, digestive system diseases, diabetes mellitus, endocrine and metabolic diseases, chronic respiratory diseases, nervous system diseases, bone and joint diseases, mental and psychological diseases, chronic kidney diseases, eye and ear diseases, congenital genetic cardiovascular and neurological diseases, infectious diseases, immune system related diseases and disorders, and blood diseases; vaccines; biological preparations for the treatment of tumors, cancer, autoimmune diseases or disorders, inflammatory diseases, cardiovascular diseases, digestive system diseases, diabetes mellitus, endocrine and metabolic diseases, chronic respiratory diseases, nervous system diseases, bone and joint diseases, mental and psychological diseases, chronic kidney diseases, eye and ear diseases, congenital genetic cardiovascular and neurological diseases, infectious diseases, immune system related diseases and disorders, and blood diseases for medical purposes; blood preparations, namely, blood for medical purposes

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 17, 2026 FINO
FINAL DISPOSITION PROCESSED
Aug 30, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 10, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 10, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 10, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 20, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jan 20, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 14, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 22, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 17, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 17, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 17, 2025 TROA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 14, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 14, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 14, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 14, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 14, 2025 COAR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 5, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 19, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 19, 2025 OPNR
REFUSAL PROCESSED BY IB
Jul 26, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 4, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jul 4, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 22, 2025 RFCR
NON-FINAL ACTION WRITTEN
Apr 21, 2025 CNRT
ASSIGNED TO EXAMINER
Apr 21, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 18, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 18, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 28, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 20, 2024 REPR